More specifically, and in keeping with the goals of establishing whether magnitude of VSI is a novel and early biomarker of AD, associations of VSI with plasma-based total and phosphorylated Tau, neurofilament (NfL), ApoE, and multimodal neuroimaging measures of Neurodegeneration will also be examined for study completeness. This evidence concerns the gene NEFL and Alzheimer disease.